Bibek Gooptu

Quick summary video of my research. Have responded prev’ly to a few posts + kind comments but only just posting it myself #CurePF @ActionPFcharity. Intro is A1ATD work #CureAlpha1 @AlphaFriend @alpha1uk @Alpha1_COPD @Alpha1UKSupport m.youtube.com/watch?v=PXfZr1…

Saw this astonishing & beautiful piece by Sadiq Ali + Vee Smith w @CWheelsTheatre for our last show @edfringe. Could tell it would be special when they sauntered up their poles in the opening darkness. Final performance today - catch it if you can!

@charlot_summers @smead2 @profserious Current model was a reasonable rationalisation of early Noughties realities. So much has changed in the meantime => it is obsolete & doesn’t stand up to scrutiny. COVID student exp’nce + current financial state of Uni.s have shown this up so clearly. Where is the new model tho?

@smead2 I agree with you, but reading the blog from @profserious leads me to confirm my view that the current financial model is not serving UK HEIs well.

This makes for thought-provoking reading….

Creative, smart & charming: @apropostheatre’s #TheTruthAboutTrees inspired our kids’ leaf drawings. Strong impressions from a gentle and beguiling show w ❤️. Go see it! The Crate, @AssemblyFest George Sq, 11.50. #EdFringe #EdinburghFringe #FringeForFamilies #FamilyTheatre

There’s Rheum in the room - hurray and welcome, Prof Adam Croft! Cross-disciplinary insights. Dissecting pro-inflammatory and pro-resolution fibroblast behav’rs in molecular and spatial detail. PRG4-def’nt synovial fibroblasts behave like IPF myofibroblasts inc mφ interactions.

Dr Chris Huntley presenting his #SANDSTONE study => Is inhalable crystal silica exposure a risk for sarcoidosis? Explored in cohort 2ry/3ry care cohort. Recruiting challenges over COVID era but now done. Adj’d OR 1.85 (lower limit of CI 1.01)! Lower exps c/w silicosis.

#MIRA is up and running! Prof ⁦@LouiseVwain⁩ kicks us off outlining a streamlined entry system for patients who want to participate in research, actively or by allowing linkage of the information we collect clinically in any case. #LeicRespCohort #MIRA4 Birmingham

Welcome’s submission to the UK Spending Review: 📈 Increase R&D intensity - invest £22bn in R&D in 2026/27 and set a longer-term ambition to become the most R&D intensive G7 economy 🏫 Fix the funding environment for UK universities to support their financial sustainability

Comin’ atcha #BTSWinter24! 2 presentations in first session Moore, Moore I hear you cry - well yes, that’s quite right: 4th floor, from 8.45. But I’m not on till midway through, so even laggardly types like me could make them.

@bedoctored @drkatyroach @Fasi_Khan10 @GauriSaini6 @Louisecrowley4 @rmahida1 @drdhruvparekh @DrAAronScott @Harvin_Der_Virk @OGA_Community @YCharOS1 @ActionPFcharity Thanks #EMIRA for the invite to a brilliant meeting. Fantastic programme showcasing Midlands ILD centre research from lab bench to clinical practice, but most importantly never losing sight of the patient perspective. Looking forward to the opportunities&collaborations at #MIRA

@drkatyroach @Fasi_Khan10 @GauriSaini6 @Drchuntley089 @Louisecrowley4 @rmahida1 @drdhruvparekh @DrAAronScott @Harvin_Der_Virk @OGA_Community @YCharOS1 @ActionPFcharity Great representation at the molecular levels too from epigenomic insights of @DrRachClifford, genetic epidemiology (great tag-teaming from @LouiseVwain & @rjallen513). My group bringing the protein & structural dimension.

@drkatyroach @Fasi_Khan10 @GauriSaini6 @Drchuntley089 @Louisecrowley4 @rmahida1 @drdhruvparekh @DrAAronScott @Harvin_Der_Virk @OGA_Community @YCharOS1 Consistently great questions from @ActionPFcharity’s Clare Hodkinson, bridging the science and patient perspectives.

Biggest #EMIRA symposium to date! Nottingham, Leicester & now Birmingham ILD patients, researchers and clinicians uniting to share their insights and move forward together to #CurePF! ⁦Inc @anmari_russell⁩ ⁦@amandatatler⁩ ⁦@LabHannan⁩ ⁦@Harvin_Der_Virk⁩…

@bedoctored @drkatyroach @Fasi_Khan10 @GauriSaini6 @Drchuntley089 @Louisecrowley4 @rmahida1 @drdhruvparekh @DrAAronScott @Harvin_Der_Virk @OGA_Community @YCharOS1 It’s great that the #EMIRA symposium was another huge success. We're thrilled that Clare was able to join you for the event. Bringing together those with lived experience, clinicians and researchers is vital for bringing about meaningful change.

@drkatyroach @Fasi_Khan10 @GauriSaini6 @Drchuntley089 @Louisecrowley4 @rmahida1 @drdhruvparekh @DrAAronScott @Harvin_Der_Virk @OGA_Community @YCharOS1 @ActionPFcharity And so to the end of the 3rd, and final EMIRA meeting. 😮 We’re going pan-regional kids: from Offa’s Dyke to the Fens, from now on… it’s #MIRA time! 🎉 The Midlands ILD Research Alliance is up and running. 🎆

@drkatyroach @Fasi_Khan10 @GauriSaini6 @Drchuntley089 @Louisecrowley4 @rmahida1 @drdhruvparekh @DrAAronScott @Harvin_Der_Virk @OGA_Community @YCharOS1 @ActionPFcharity A shift of pace for the afternoon: discussions on patient priorities & research themes, agreements & action points noted.

@ActionPFcharity @drkatyroach @Fasi_Khan10 @GauriSaini6 @Drchuntley089 @Louisecrowley4 @rmahida1 @drdhruvparekh @DrAAronScott @Harvin_Der_Virk @OGA_Community @YCharOS1 💯

@drkatyroach @Fasi_Khan10 @GauriSaini6 @Drchuntley089 @Louisecrowley4 @rmahida1 @drdhruvparekh @DrAAronScott @Harvin_Der_Virk @OGA_Community @YCharOS1 .@PeptiMatrix CEO John Curd and @AmandaTGoodwin @amandatatler PhD student Arshad Hashmat closing the morning telling us about optimising the experimental hydrogels to mimic the fibrotic matrix environment.

@drkatyroach @Fasi_Khan10 @GauriSaini6 @Drchuntley089 @Louisecrowley4 @rmahida1 @drdhruvparekh @DrAAronScott @Harvin_Der_Virk and Michael Biddle now presenting on their @OGA_Community and @YCharOS1 initiatives to improve research tools in ILD research, particularly reliability of antibodies.